![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Idenix May Drop Delayed Hepatitis C Drug for New Versions
Idenix May Drop Delayed Hepatitis C Drug for New Versions
January 10, 2013
Idenix Pharmaceuticals, a developer of hepatitis C drugs, may shelve experimental treatments currently on hold by U.S. regulators and focus on different versions, CEO Ron Renaud said.
Bloomberg
Bloomberg
Upcoming Events
-
21Oct